Gene symbol: Myc

Also known as: mMyc; c-myc; RNCMYC

Organism: Rattus norvegicus

Summary: The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma, in human. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini, in human and mouse. Rat mRNA also has a similarly placed CUG upstream of the AUG start site, suggesting that it may also produce two Myc proteins. [provided by RefSeq, Jul 2008]

NCBI gene ID: 24577 Ensembl:ENSRNOG00000004500 AllianceGenome:RGD:3130


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0000082 G1/S transition of mitotic cell cycle
Process GO:0000122 Negative regulation of transcription by RNA polymerase II
Process GO:0000165 MAPK cascade
Process GO:0000278 Mitotic cell cycle
Process GO:0000320 Re-entry into mitotic cell cycle
Process GO:0001101 Response to acid chemical
Process GO:0001501 Skeletal system development
Process GO:0001541 Ovarian follicle development
Process GO:0001655 Urogenital system development
Process GO:0001657 Ureteric bud development
Process GO:0001658 Branching involved in ureteric bud morphogenesis
Process GO:0001666 Response to hypoxia
Process GO:0001701 In utero embryonic development
Process GO:0001763 Morphogenesis of a branching structure
Process GO:0001775 Cell activation
Process GO:0001783 B cell apoptotic process
Process GO:0001822 Kidney development
Process GO:0001823 Mesonephros development
Process GO:0001866 NK T cell proliferation
Process GO:0001889 Liver development
Process GO:0002009 Morphogenesis of an epithelium
Process GO:0002053 Positive regulation of mesenchymal cell proliferation
Process GO:0002082 Regulation of oxidative phosphorylation
Process GO:0002376 Immune system process
Process GO:0002682 Regulation of immune system process
Process GO:0002683 Negative regulation of immune system process
Process GO:0002761 Regulation of myeloid leukocyte differentiation
Process GO:0002762 Negative regulation of myeloid leukocyte differentiation
Process GO:0002902 Regulation of B cell apoptotic process
Process GO:0002904 Positive regulation of B cell apoptotic process
Process GO:0003006 Developmental process involved in reproduction
Process GO:0003008 System process
Process GO:0005975 Carbohydrate metabolic process
Process GO:0005996 Monosaccharide metabolic process
Process GO:0006006 Glucose metabolic process
Process GO:0006109 Regulation of carbohydrate metabolic process
Process GO:0006110 Regulation of glycolytic process
Process GO:0006139 Nucleobase-containing compound metabolic process
Process GO:0006140 Regulation of nucleotide metabolic process
Process GO:0006325 Chromatin organization
Process GO:0006338 Chromatin remodeling
Process GO:0006351 Transcription, DNA-templated
Process GO:0006352 DNA-templated transcription, initiation
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006357 Regulation of transcription by RNA polymerase II
Process GO:0006366 Transcription by RNA polymerase II
Process GO:0006508 Proteolysis
Process GO:0006725 Cellular aromatic compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006810 Transport
Process GO:0006811 Ion transport
Process GO:0006820 Anion transport
Process GO:0006848 Pyruvate transport
Process GO:0006865 Amino acid transport
Process GO:0006873 Cellular ion homeostasis
Process GO:0006875 Cellular metal ion homeostasis
Process GO:0006879 Cellular iron ion homeostasis
Process GO:0006915 Apoptotic process
Process GO:0006919 Activation of cysteine-type endopeptidase activity involved in apoptotic process
Process GO:0006950 Response to stress
Process GO:0006952 Defense response
Process GO:0006955 Immune response
Process GO:0006974 Cellular response to DNA damage stimulus
Process GO:0006996 Organelle organization
Process GO:0007005 Mitochondrion organization
Process GO:0007006 Mitochondrial membrane organization
Process GO:0007007 Inner mitochondrial membrane organization
Process GO:0007049 Cell cycle
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007267 Cell-cell signaling
Process GO:0007275 Multicellular organism development
Process GO:0007276 Gamete generation
Process GO:0007292 Female gamete generation
Process GO:0007346 Regulation of mitotic cell cycle
Process GO:0007399 Nervous system development
Process GO:0007417 Central nervous system development
Process GO:0007420 Brain development
Process GO:0007423 Sensory organ development
Process GO:0007517 Muscle organ development
Process GO:0007519 Skeletal muscle tissue development
Process GO:0007548 Sex differentiation
Process GO:0007600 Sensory perception
Process GO:0007605 Sensory perception of sound
Process GO:0008152 Metabolic process
Process GO:0008219 Cell death
Process GO:0008283 Cell population proliferation
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008285 Negative regulation of cell population proliferation
Process GO:0008406 Gonad development
Process GO:0008585 Female gonad development
Process GO:0008630 Intrinsic apoptotic signaling pathway in response to DNA damage
Process GO:0009058 Biosynthetic process
Process GO:0009059 Macromolecule biosynthetic process
Process GO:0009314 Response to radiation
Process GO:0009410 Response to xenobiotic stimulus
Process GO:0009411 Response to UV
Process GO:0009415 Response to water
Process GO:0009416 Response to light stimulus
Process GO:0009581 Detection of external stimulus
Process GO:0009582 Detection of abiotic stimulus
Process GO:0009605 Response to external stimulus
Process GO:0009607 Response to biotic stimulus
Process GO:0009611 Response to wounding
Process GO:0009612 Response to mechanical stimulus
Process GO:0009628 Response to abiotic stimulus
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009743 Response to carbohydrate
Process GO:0009790 Embryo development
Process GO:0009792 Embryo development ending in birth or egg hatching
Process GO:0009887 Animal organ morphogenesis
Process GO:0009888 Tissue development
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009890 Negative regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009894 Regulation of catabolic process
Process GO:0009896 Positive regulation of catabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010035 Response to inorganic substance
Process GO:0010212 Response to ionizing radiation
Process GO:0010243 Response to organonitrogen compound
Process GO:0010332 Response to gamma radiation
Process GO:0010464 Regulation of mesenchymal cell proliferation
Process GO:0010467 Gene expression
Process GO:0010468 Regulation of gene expression
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010558 Negative regulation of macromolecule biosynthetic process
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010564 Regulation of cell cycle process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010629 Negative regulation of gene expression
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010720 Positive regulation of cell development
Process GO:0010827 Regulation of glucose transmembrane transport
Process GO:0010829 Negative regulation of glucose transmembrane transport
Process GO:0010918 Positive regulation of mitochondrial membrane potential
Process GO:0010941 Regulation of cell death
Process GO:0010942 Positive regulation of cell death
Process GO:0010950 Positive regulation of endopeptidase activity
Process GO:0010952 Positive regulation of peptidase activity
Process GO:0012501 Programmed cell death
Process GO:0014013 Regulation of gliogenesis
Process GO:0014015 Positive regulation of gliogenesis
Process GO:0014070 Response to organic cyclic compound
Process GO:0014910 Regulation of smooth muscle cell migration
Process GO:0014911 Positive regulation of smooth muscle cell migration
Process GO:0015711 Organic anion transport
Process GO:0015718 Monocarboxylic acid transport
Process GO:0015727 Lactate transport
Process GO:0015849 Organic acid transport
Process GO:0015850 Organic hydroxy compound transport
Process GO:0016032 Viral process
Process GO:0016043 Cellular component organization
Process GO:0016055 Wnt signaling pathway
Process GO:0016070 RNA metabolic process
Process GO:0016485 Protein processing
Process GO:0018130 Heterocycle biosynthetic process
Process GO:0019048 Modulation by virus of host process
Process GO:0019054 Modulation by virus of host cellular process
Process GO:0019087 Transformation of host cell by virus
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019318 Hexose metabolic process
Process GO:0019438 Aromatic compound biosynthetic process
Process GO:0019538 Protein metabolic process
Process GO:0019725 Cellular homeostasis
Process GO:0019953 Sexual reproduction
Process GO:0021536 Diencephalon development
Process GO:0021761 Limbic system development
Process GO:0021854 Hypothalamus development
Process GO:0022402 Cell cycle process
Process GO:0022411 Cellular component disassembly
Process GO:0022414 Reproductive process
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0030003 Cellular cation homeostasis
Process GO:0030154 Cell differentiation
Process GO:0030162 Regulation of proteolysis
Process GO:0030334 Regulation of cell migration
Process GO:0030335 Positive regulation of cell migration
Process GO:0030728 Ovulation
Process GO:0030808 Regulation of nucleotide biosynthetic process
Process GO:0030810 Positive regulation of nucleotide biosynthetic process
Process GO:0030900 Forebrain development
Process GO:0031099 Regeneration
Process GO:0031100 Animal organ regeneration
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031324 Negative regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031327 Negative regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031329 Regulation of cellular catabolic process
Process GO:0031331 Positive regulation of cellular catabolic process
Process GO:0032091 Negative regulation of protein binding
Process GO:0032204 Regulation of telomere maintenance
Process GO:0032355 Response to estradiol
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032504 Multicellular organism reproduction
Process GO:0032526 Response to retinoic acid
Process GO:0032774 RNA biosynthetic process
Process GO:0032868 Response to insulin
Process GO:0032869 Cellular response to insulin stimulus
Process GO:0032870 Cellular response to hormone stimulus
Process GO:0032879 Regulation of localization
Process GO:0032943 Mononuclear cell proliferation
Process GO:0032984 Protein-containing complex disassembly
Process GO:0032986 protein-DNA complex disassembly
Process GO:0033043 Regulation of organelle organization
Process GO:0033044 Regulation of chromosome organization
Process GO:0033554 Cellular response to stress
Process GO:0033574 Response to testosterone
Process GO:0033993 Response to lipid
Process GO:0034097 Response to cytokine
Process GO:0034220 Ion transmembrane transport
Process GO:0034341 Response to interferon-gamma
Process GO:0034641 Cellular nitrogen compound metabolic process
Process GO:0034644 Cellular response to UV
Process GO:0034654 Nucleobase-containing compound biosynthetic process
Process GO:0034698 Response to gonadotropin
Process GO:0034762 Regulation of transmembrane transport
Process GO:0034763 Negative regulation of transmembrane transport
Process GO:0035239 Tube morphogenesis
Process GO:0035295 Tube development
Process GO:0035455 Response to interferon-alpha
Process GO:0035457 Cellular response to interferon-alpha
Process GO:0035556 Intracellular signal transduction
Process GO:0035821 Modulation of process of another organism
Process GO:0035873 Lactate transmembrane transport
Process GO:0035879 Plasma membrane lactate transport
Process GO:0035914 Skeletal muscle cell differentiation
Process GO:0036119 Response to platelet-derived growth factor
Process GO:0036120 Cellular response to platelet-derived growth factor stimulus
Process GO:0036293 Response to decreased oxygen levels
Process GO:0036294 Cellular response to decreased oxygen levels
Process GO:0040012 Regulation of locomotion
Process GO:0040017 Positive regulation of locomotion
Process GO:0042098 T cell proliferation
Process GO:0042110 T cell activation
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042325 Regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042391 Regulation of membrane potential
Process GO:0042471 Ear morphogenesis
Process GO:0042474 Middle ear morphogenesis
Process GO:0042592 Homeostatic process
Process GO:0042981 Regulation of apoptotic process
Process GO:0043009 Chordate embryonic development
Process GO:0043065 Positive regulation of apoptotic process
Process GO:0043066 Negative regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043068 Positive regulation of programmed cell death
Process GO:0043069 Negative regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043170 Macromolecule metabolic process
Process GO:0043207 Response to external biotic stimulus
Process GO:0043279 Response to alkaloid
Process GO:0043280 Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
Process GO:0043281 Regulation of cysteine-type endopeptidase activity involved in apoptotic process
Process GO:0043388 Positive regulation of DNA binding
Process GO:0043393 Regulation of protein binding
Process GO:0043434 Response to peptide hormone
Process GO:0043457 Regulation of cellular respiration
Process GO:0043467 Regulation of generation of precursor metabolites and energy
Process GO:0043470 Regulation of carbohydrate catabolic process
Process GO:0043473 Pigmentation
Process GO:0043583 Ear development
Process GO:0043627 Response to estrogen
Process GO:0043933 Protein-containing complex organization
Process GO:0044003 Modulation by symbiont of host process
Process GO:0044030 Regulation of DNA methylation
Process GO:0044068 Modulation by symbiont of host cellular process
Process GO:0044092 Negative regulation of molecular function
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044271 Cellular nitrogen compound biosynthetic process
Process GO:0044281 Small molecule metabolic process
Process GO:0044336 Canonical Wnt signaling pathway involved in negative regulation of apoptotic process
Process GO:0044337 Canonical Wnt signaling pathway involved in positive regulation of apoptotic process
Process GO:0044344 Cellular response to fibroblast growth factor stimulus
Process GO:0044403 Biological process involved in symbiotic interaction
Process GO:0044419 Biological process involved in interspecies interaction between organisms
Process GO:0044752 Response to human chorionic gonadotropin
Process GO:0044770 Cell cycle phase transition
Process GO:0044772 Mitotic cell cycle phase transition
Process GO:0044843 Cell cycle G1/S phase transition
Process GO:0045023 G0 to G1 transition
Process GO:0045087 Innate immune response
Process GO:0045137 Development of primary sexual characteristics
Process GO:0045321 Leukocyte activation
Process GO:0045471 Response to ethanol
Process GO:0045595 Regulation of cell differentiation
Process GO:0045596 Negative regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0045637 Regulation of myeloid cell differentiation
Process GO:0045638 Negative regulation of myeloid cell differentiation
Process GO:0045655 Regulation of monocyte differentiation
Process GO:0045656 Negative regulation of monocyte differentiation
Process GO:0045787 Positive regulation of cell cycle
Process GO:0045821 Positive regulation of glycolytic process
Process GO:0045838 Positive regulation of membrane potential
Process GO:0045862 Positive regulation of proteolysis
Process GO:0045892 Negative regulation of transcription, DNA-templated
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045913 Positive regulation of carbohydrate metabolic process
Process GO:0045934 Negative regulation of nucleobase-containing compound metabolic process
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045944 Positive regulation of transcription by RNA polymerase II
Process GO:0045981 Positive regulation of nucleotide metabolic process
Process GO:0046324 Regulation of glucose import
Process GO:0046325 Negative regulation of glucose import
Process GO:0046483 Heterocycle metabolic process
Process GO:0046545 Development of primary female sexual characteristics
Process GO:0046631 Alpha-beta T cell activation
Process GO:0046633 Alpha-beta T cell proliferation
Process GO:0046649 Lymphocyte activation
Process GO:0046651 Lymphocyte proliferation
Process GO:0046660 Female sex differentiation
Process GO:0046685 Response to arsenic-containing substance
Process GO:0046717 Acid secretion
Process GO:0046722 Lactic acid secretion
Process GO:0046898 Response to cycloheximide
Process GO:0046903 Secretion
Process GO:0046916 Cellular transition metal ion homeostasis
Process GO:0046942 Carboxylic acid transport
Process GO:0048145 Regulation of fibroblast proliferation
Process GO:0048146 Positive regulation of fibroblast proliferation
Process GO:0048147 Negative regulation of fibroblast proliferation
Process GO:0048513 Animal organ development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048562 Embryonic organ morphogenesis
Process GO:0048568 Embryonic organ development
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048598 Embryonic morphogenesis
Process GO:0048608 Reproductive structure development
Process GO:0048609 Multicellular organismal reproductive process
Process GO:0048660 Regulation of smooth muscle cell proliferation
Process GO:0048661 Positive regulation of smooth muscle cell proliferation
Process GO:0048705 Skeletal system morphogenesis
Process GO:0048729 Tissue morphogenesis
Process GO:0048731 System development
Process GO:0048732 Gland development
Process GO:0048754 Branching morphogenesis of an epithelial tube
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0048878 Chemical homeostasis
Process GO:0050678 Regulation of epithelial cell proliferation
Process GO:0050679 Positive regulation of epithelial cell proliferation
Process GO:0050767 Regulation of neurogenesis
Process GO:0050769 Positive regulation of neurogenesis
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050801 Ion homeostasis
Process GO:0050877 Nervous system process
Process GO:0050896 Response to stimulus
Process GO:0050906 Detection of stimulus involved in sensory perception
Process GO:0050910 Detection of mechanical stimulus involved in sensory perception of sound
Process GO:0050954 Sensory perception of mechanical stimulus
Process GO:0050974 Detection of mechanical stimulus involved in sensory perception
Process GO:0050982 Detection of mechanical stimulus
Process GO:0051049 Regulation of transport
Process GO:0051051 Negative regulation of transport
Process GO:0051052 Regulation of DNA metabolic process
Process GO:0051054 Positive regulation of DNA metabolic process
Process GO:0051093 Negative regulation of developmental process
Process GO:0051094 Positive regulation of developmental process
Process GO:0051098 Regulation of binding
Process GO:0051099 Positive regulation of binding
Process GO:0051100 Negative regulation of binding
Process GO:0051101 Regulation of DNA binding
Process GO:0051128 Regulation of cellular component organization
Process GO:0051132 NK T cell activation
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051172 Negative regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051253 Negative regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051276 Chromosome organization
Process GO:0051302 Regulation of cell division
Process GO:0051336 Regulation of hydrolase activity
Process GO:0051338 Regulation of transferase activity
Process GO:0051345 Positive regulation of hydrolase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051599 Response to hydrostatic pressure
Process GO:0051604 Protein maturation
Process GO:0051606 Detection of stimulus
Process GO:0051701 Biological process involved in interaction with host
Process GO:0051707 Response to other organism
Process GO:0051716 Cellular response to stimulus
Process GO:0051726 Regulation of cell cycle
Process GO:0051782 Negative regulation of cell division
Process GO:0051881 Regulation of mitochondrial membrane potential
Process GO:0051960 Regulation of nervous system development
Process GO:0051962 Positive regulation of nervous system development
Process GO:0051972 Regulation of telomerase activity
Process GO:0051973 Positive regulation of telomerase activity
Process GO:0052547 Regulation of peptidase activity
Process GO:0052548 Regulation of endopeptidase activity
Process GO:0055065 Metal ion homeostasis
Process GO:0055072 Iron ion homeostasis
Process GO:0055076 Transition metal ion homeostasis
Process GO:0055080 Cation homeostasis
Process GO:0055082 Cellular chemical homeostasis
Process GO:0055085 Transmembrane transport
Process GO:0060070 Canonical Wnt signaling pathway
Process GO:0060251 Regulation of glial cell proliferation
Process GO:0060252 Positive regulation of glial cell proliferation
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060260 Regulation of transcription initiation from RNA polymerase II promoter
Process GO:0060261 Positive regulation of transcription initiation from RNA polymerase II promoter
Process GO:0060284 Regulation of cell development
Process GO:0060322 Head development
Process GO:0060416 Response to growth hormone
Process GO:0060429 Epithelium development
Process GO:0060537 Muscle tissue development
Process GO:0060538 Skeletal muscle organ development
Process GO:0060548 Negative regulation of cell death
Process GO:0060562 Epithelial tube morphogenesis
Process GO:0060675 Ureteric bud morphogenesis
Process GO:0060993 Kidney morphogenesis
Process GO:0061008 Hepaticobiliary system development
Process GO:0061024 Membrane organization
Process GO:0061061 Muscle structure development
Process GO:0061138 Morphogenesis of a branching epithelium
Process GO:0061326 Renal tubule development
Process GO:0061333 Renal tubule morphogenesis
Process GO:0061458 Reproductive system development
Process GO:0062012 Regulation of small molecule metabolic process
Process GO:0062013 Positive regulation of small molecule metabolic process
Process GO:0062197 Cellular response to chemical stress
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070227 Lymphocyte apoptotic process
Process GO:0070228 Regulation of lymphocyte apoptotic process
Process GO:0070230 Positive regulation of lymphocyte apoptotic process
Process GO:0070371 ERK1 and ERK2 cascade
Process GO:0070482 Response to oxygen levels
Process GO:0070555 Response to interleukin-1
Process GO:0070661 Leukocyte proliferation
Process GO:0070848 Response to growth factor
Process GO:0070849 Response to epidermal growth factor
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071214 Cellular response to abiotic stimulus
Process GO:0071229 Cellular response to acid chemical
Process GO:0071243 Cellular response to arsenic-containing substance
Process GO:0071300 Cellular response to retinoic acid
Process GO:0071310 Cellular response to organic substance
Process GO:0071322 Cellular response to carbohydrate stimulus
Process GO:0071345 Cellular response to cytokine stimulus
Process GO:0071346 Cellular response to interferon-gamma
Process GO:0071347 Cellular response to interleukin-1
Process GO:0071363 Cellular response to growth factor stimulus
Process GO:0071364 Cellular response to epidermal growth factor stimulus
Process GO:0071375 Cellular response to peptide hormone stimulus
Process GO:0071378 Cellular response to growth hormone stimulus
Process GO:0071391 Cellular response to estrogen stimulus
Process GO:0071394 Cellular response to testosterone stimulus
Process GO:0071396 Cellular response to lipid
Process GO:0071407 Cellular response to organic cyclic compound
Process GO:0071409 Cellular response to cycloheximide
Process GO:0071417 Cellular response to organonitrogen compound
Process GO:0071453 Cellular response to oxygen levels
Process GO:0071456 Cellular response to hypoxia
Process GO:0071462 Cellular response to water stimulus
Process GO:0071464 Cellular response to hydrostatic pressure
Process GO:0071466 Cellular response to xenobiotic stimulus
Process GO:0071478 Cellular response to radiation
Process GO:0071482 Cellular response to light stimulus
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071702 Organic substance transport
Process GO:0071704 Organic substance metabolic process
Process GO:0071705 Nitrogen compound transport
Process GO:0071774 Response to fibroblast growth factor
Process GO:0071824 protein-DNA complex subunit organization
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0071887 Leukocyte apoptotic process
Process GO:0072001 Renal system development
Process GO:0072006 Nephron development
Process GO:0072009 Nephron epithelium development
Process GO:0072028 Nephron morphogenesis
Process GO:0072073 Kidney epithelium development
Process GO:0072078 Nephron tubule morphogenesis
Process GO:0072080 Nephron tubule development
Process GO:0072088 Nephron epithelium morphogenesis
Process GO:0072163 Mesonephric epithelium development
Process GO:0072164 Mesonephric tubule development
Process GO:0072171 Mesonephric tubule morphogenesis
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0080135 Regulation of cellular response to stress
Process GO:0090095 Regulation of metanephric cap mesenchymal cell proliferation
Process GO:0090096 Positive regulation of metanephric cap mesenchymal cell proliferation
Process GO:0090183 Regulation of kidney development
Process GO:0090184 Positive regulation of kidney development
Process GO:0090304 Nucleic acid metabolic process
Process GO:0090596 Sensory organ morphogenesis
Process GO:0097190 Apoptotic signaling pathway
Process GO:0097193 Intrinsic apoptotic signaling pathway
Process GO:0097305 Response to alcohol
Process GO:0097306 Cellular response to alcohol
Process GO:0097421 Liver regeneration
Process GO:0097659 Nucleic acid-templated transcription
Process GO:0098542 Defense response to other organism
Process GO:0098656 Anion transmembrane transport
Process GO:0098771 Inorganic ion homeostasis
Process GO:0104004 Cellular response to environmental stimulus
Process GO:0198738 Cell-cell signaling by wnt
Process GO:1900371 Regulation of purine nucleotide biosynthetic process
Process GO:1900373 Positive regulation of purine nucleotide biosynthetic process
Process GO:1900542 Regulation of purine nucleotide metabolic process
Process GO:1900544 Positive regulation of purine nucleotide metabolic process
Process GO:1901360 Organic cyclic compound metabolic process
Process GO:1901362 Organic cyclic compound biosynthetic process
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901576 Organic substance biosynthetic process
Process GO:1901652 Response to peptide
Process GO:1901653 Cellular response to peptide
Process GO:1901654 Response to ketone
Process GO:1901655 Cellular response to ketone
Process GO:1901698 Response to nitrogen compound
Process GO:1901699 Cellular response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1901722 Regulation of cell proliferation involved in kidney development
Process GO:1901724 Positive regulation of cell proliferation involved in kidney development
Process GO:1901796 Regulation of signal transduction by p53 class mediator
Process GO:1901798 Positive regulation of signal transduction by p53 class mediator
Process GO:1901857 Positive regulation of cellular respiration
Process GO:1902105 Regulation of leukocyte differentiation
Process GO:1902106 Negative regulation of leukocyte differentiation
Process GO:1902253 Regulation of intrinsic apoptotic signaling pathway by p53 class mediator
Process GO:1902255 Positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902679 Negative regulation of RNA biosynthetic process
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1902893 Regulation of miRNA transcription
Process GO:1902895 Positive regulation of miRNA transcription
Process GO:1903047 Mitotic cell cycle process
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903507 Negative regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:1903578 Regulation of ATP metabolic process
Process GO:1903580 Positive regulation of ATP metabolic process
Process GO:1903706 Regulation of hemopoiesis
Process GO:1903707 Negative regulation of hemopoiesis
Process GO:1903715 Regulation of aerobic respiration
Process GO:1903825 Organic acid transmembrane transport
Process GO:1903840 Response to arsenite(3-)
Process GO:1903841 Cellular response to arsenite(3-)
Process GO:1903842 Response to arsenite ion
Process GO:1903843 Cellular response to arsenite ion
Process GO:1903862 Positive regulation of oxidative phosphorylation
Process GO:1904385 Cellular response to angiotensin
Process GO:1904585 Response to putrescine
Process GO:1904586 Cellular response to putrescine
Process GO:1904619 Response to dimethyl sulfoxide
Process GO:1904620 Cellular response to dimethyl sulfoxide
Process GO:1904627 Response to phorbol 13-acetate 12-myristate
Process GO:1904628 Cellular response to phorbol 13-acetate 12-myristate
Process GO:1904672 Regulation of somatic stem cell population maintenance
Process GO:1905039 Carboxylic acid transmembrane transport
Process GO:1905114 Cell surface receptor signaling pathway involved in cell-cell signaling
Process GO:1905643 Positive regulation of DNA methylation
Process GO:1990637 Response to prolactin
Process GO:1990646 Cellular response to prolactin
Process GO:1990776 Response to angiotensin
Process GO:1990839 Response to endothelin
Process GO:1990840 Response to lectin
Process GO:1990858 Cellular response to lectin
Process GO:1990859 Cellular response to endothelin
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000036 Regulation of stem cell population maintenance
Process GO:2000106 Regulation of leukocyte apoptotic process
Process GO:2000108 Positive regulation of leukocyte apoptotic process
Process GO:2000116 Regulation of cysteine-type endopeptidase activity
Process GO:2000142 Regulation of DNA-templated transcription, initiation
Process GO:2000144 Positive regulation of DNA-templated transcription, initiation
Process GO:2000145 Regulation of cell motility
Process GO:2000147 Positive regulation of cell motility
Process GO:2000278 Regulation of DNA biosynthetic process
Process GO:2000573 Positive regulation of DNA biosynthetic process
Process GO:2000628 Regulation of miRNA metabolic process
Process GO:2000630 Positive regulation of miRNA metabolic process
Process GO:2001020 Regulation of response to DNA damage stimulus
Process GO:2001022 Positive regulation of response to DNA damage stimulus
Process GO:2001056 Positive regulation of cysteine-type endopeptidase activity
Process GO:2001141 Regulation of RNA biosynthetic process
Process GO:2001169 Regulation of ATP biosynthetic process
Process GO:2001171 Positive regulation of ATP biosynthetic process
Process GO:2001233 Regulation of apoptotic signaling pathway
Process GO:2001235 Positive regulation of apoptotic signaling pathway
Process GO:2001242 Regulation of intrinsic apoptotic signaling pathway
Process GO:2001244 Positive regulation of intrinsic apoptotic signaling pathway
Component GO:0000785 Chromatin
Component GO:0000791 Euchromatin
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0005635 Nuclear envelope
Component GO:0005654 Nucleoplasm
Component GO:0005667 Transcription regulator complex
Component GO:0005694 Chromosome
Component GO:0005730 Nucleolus
Component GO:0005737 Cytoplasm
Component GO:0005739 Mitochondrion
Component GO:0005783 Endoplasmic reticulum
Component GO:0005791 Rough endoplasmic reticulum
Component GO:0005819 Spindle
Component GO:0005856 Cytoskeleton
Component GO:0012505 Endomembrane system
Component GO:0015630 Microtubule cytoskeleton
Component GO:0016604 Nuclear body
Component GO:0017053 Transcription repressor complex
Component GO:0030424 Axon
Component GO:0031967 Organelle envelope
Component GO:0031974 Membrane-enclosed lumen
Component GO:0031975 Envelope
Component GO:0031981 Nuclear lumen
Component GO:0032991 Protein-containing complex
Component GO:0042995 Cell projection
Component GO:0043005 Neuron projection
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043228 Non-membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043232 Intracellular non-membrane-bounded organelle
Component GO:0043233 Organelle lumen
Component GO:0044195 Nucleoplasmic reticulum
Component GO:0048471 Perinuclear region of cytoplasm
Component GO:0070013 Intracellular organelle lumen
Component GO:0071943 Myc-Max complex
Component GO:0090571 RNA polymerase II transcription repressor complex
Component GO:0090575 RNA polymerase II transcription regulator complex
Component GO:0110165 Cellular anatomical entity
Component GO:0120025 Plasma membrane bounded cell projection
Component GO:0140513 Nuclear protein-containing complex
Function GO:0000976 Transcription cis-regulatory region binding
Function GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding
Function GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
Function GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
Function GO:0000987 Cis-regulatory region sequence-specific DNA binding
Function GO:0001046 Core promoter sequence-specific DNA binding
Function GO:0001067 Transcription regulatory region nucleic acid binding
Function GO:0001216 DNA-binding transcription activator activity
Function GO:0001217 DNA-binding transcription repressor activity
Function GO:0001221 Transcription coregulator binding
Function GO:0001227 DNA-binding transcription repressor activity, RNA polymerase II-specific
Function GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific
Function GO:0003676 Nucleic acid binding
Function GO:0003677 DNA binding
Function GO:0003690 Double-stranded DNA binding
Function GO:0003700 DNA-binding transcription factor activity
Function GO:0003723 RNA binding
Function GO:0003729 mRNA binding
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0008134 Transcription factor binding
Function GO:0019899 Enzyme binding
Function GO:0031369 Translation initiation factor binding
Function GO:0031625 Ubiquitin protein ligase binding
Function GO:0043565 Sequence-specific DNA binding
Function GO:0044389 Ubiquitin-like protein ligase binding
Function GO:0044877 Protein-containing complex binding
Function GO:0046983 Protein dimerization activity
Function GO:0070888 E-box binding
Function GO:0071074 Eukaryotic initiation factor eIF2 binding
Function GO:0097159 Organic cyclic compound binding
Function GO:0140110 Transcription regulator activity
Function GO:0140297 DNA-binding transcription factor binding
Function GO:1901363 Heterocyclic compound binding
Function GO:1990837 Sequence-specific double-stranded DNA binding

Pathway annotation


Category Term ID Term description
RCTM RNO-212436 Generic Transcription Pathway
RCTM RNO-392499 Metabolism of proteins
RCTM RNO-5688426 Deubiquitination
RCTM RNO-5689880 Ub-specific processing proteases
RCTM RNO-597592 Post-translational protein modification
RCTM RNO-73857 RNA Polymerase II Transcription
RCTM RNO-74160 Gene expression (Transcription)
RCTM RNO-8864260 Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
RCTM RNO-8866911 TFAP2 (AP-2) family regulates transcription of cell cycle factors
KEGG rno04010 MAPK signaling pathway
KEGG rno04012 ErbB signaling pathway
KEGG rno04110 Cell cycle
KEGG rno04151 PI3K-Akt signaling pathway
KEGG rno04218 Cellular senescence
KEGG rno04310 Wnt signaling pathway
KEGG rno04350 TGF-beta signaling pathway
KEGG rno04390 Hippo signaling pathway
KEGG rno04550 Signaling pathways regulating pluripotency of stem cells
KEGG rno04630 JAK-STAT signaling pathway
KEGG rno04919 Thyroid hormone signaling pathway
KEGG rno05132 Salmonella infection
KEGG rno05160 Hepatitis C
KEGG rno05161 Hepatitis B
KEGG rno05163 Human cytomegalovirus infection
KEGG rno05166 Human T-cell leukemia virus 1 infection
KEGG rno05167 Kaposi sarcoma-associated herpesvirus infection
KEGG rno05169 Epstein-Barr virus infection
KEGG rno05200 Pathways in cancer
KEGG rno05202 Transcriptional misregulation in cancer
KEGG rno05205 Proteoglycans in cancer
KEGG rno05206 MicroRNAs in cancer
KEGG rno05207 Chemical carcinogenesis - receptor activation
KEGG rno05210 Colorectal cancer
KEGG rno05213 Endometrial cancer
KEGG rno05216 Thyroid cancer
KEGG rno05219 Bladder cancer
KEGG rno05220 Chronic myeloid leukemia
KEGG rno05221 Acute myeloid leukemia
KEGG rno05222 Small cell lung cancer
KEGG rno05224 Breast cancer
KEGG rno05225 Hepatocellular carcinoma
KEGG rno05226 Gastric cancer
KEGG rno05230 Central carbon metabolism in cancer

Expression profile of Myc in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 11.369875
GSM2685202 MX2 tissue: Myocardium gender: female 11.373672
GSM2685203 MX3 tissue: Myocardium gender: female 11.320953
GSM2685204 MX4 tissue: Myocardium gender: male 11.546958
GSM2685205 DZ1 tissue: Myocardium gender: male 10.463606
GSM2685206 DZ2 tissue: Myocardium gender: male 10.001235
GSM2685207 DZ3 tissue: Myocardium gender: female 9.866456
GSM2685208 DZ4 tissue: Myocardium gender: female 10.4319105
GSM2685209 JJ1 tissue: Myocardium gender: male 11.745709
GSM2685210 JJ2 tissue: Myocardium gender: female 10.779916
GSM2685211 JJ3 tissue: Myocardium gender: female 11.417258
GSM2685212 JJ4 tissue: Myocardium gender: male 11.732915
GSM2685213 NG1 tissue: Myocardium gender: male 11.474298
GSM2685214 NG2 tissue: Myocardium gender: female 10.5984335
GSM2685215 NG3 tissue: Myocardium gender: male 11.616209
GSM2685216 NG4 tissue: Myocardium gender: female 11.199288
GSM2685217 YL1 tissue: Myocardium gender: male 11.031332
GSM2685218 YL2 tissue: Myocardium gender: male 11.491668
GSM2685219 YL3 tissue: Myocardium gender: female 12.037105
GSM2685220 YL4 tissue: Myocardium gender: female 11.559549
GSM2685221 QC1 tissue: Myocardium gender: male 11.432699
GSM2685222 QC2 tissue: Myocardium gender: male 11.199288
GSM2685223 QC3 tissue: Myocardium gender: female 11.336525
GSM2685224 QC4 tissue: Myocardium gender: female 11.925725

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.603472623
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.514227355
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.666416633
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.354836851
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.58710414
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.321905476

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1295.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1264.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 3019.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 926.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 739.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 687.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 675.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1546.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 787.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 890.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 979.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1479.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 849.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1231.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 2581.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 550.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.428897
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.581778
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.419416
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.561661
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.369408
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.400265

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 1.441
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 1.494
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 1.849
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 1.234
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 0.728

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 6.738367395
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 6.883701595
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 7.343186802

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 587.95
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 439.65
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 356.85
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 561.4
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 528.4000000000001
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 156.5
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 179.0
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 208.05
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 164.75
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 111.94999999999999
GSM27494 CTL_a (control, 1st replicate) 236.6
GSM27495 CTL_b (control, 2nd replicate) 488.2
GSM27496 CTL_c (control, 3rd replicate) 383.35
GSM27497 CTL_d (control, 4th replicate) 307.9
GSM27498 CTL_e (control, 5th replicate) 234.5
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 533.75
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 692.45
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 685.5
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 563.3
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 196.39999999999998
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 225.25
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 284.15
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 256.8
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 358.15
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 296.9
GSM27509 ISCH_a (ischemia, 1st replicate) 203.05
GSM27510 ISCH_b (ischemia, 2nd replicate) 380.0
GSM27511 ISCH_c (ischemia, 3rd replicate) 536.6
GSM27512 ISCH_d (ischemia, 4th replicate) 465.55
GSM27513 ISCH_e (ischemia, 5th replicate) 252.15

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 72.1
GSM30791 baseline control 02 male, 275-300g 30.9
GSM30792 baseline control 03 male, 275-300g 74.3
GSM30793 baseline control 04 male, 275-300g 53.0
GSM30794 baseline control 05 male, 275-300g 51.6
GSM30795 baseline control 06 male, 275-300g 43.9
GSM30796 baseline control 07 male, 275-300g 61.5
GSM30797 baseline control 08 male, 275-300g 40.4
GSM30798 baseline control 09 male, 275-300g 80.1
GSM30799 pain 01 22.0
GSM30800 pain 02 67.8
GSM30801 pain 03 56.8
GSM30802 pain 04 53.3
GSM30803 pain 05 51.5
GSM30804 FC 01 28.6
GSM30805 FC 02 24.1
GSM30806 FC 03 89.6
GSM30807 FC 04 53.8
GSM30808 FC 05 90.6
GSM30809 IFC 01 79.6
GSM30810 IFC 02 47.9
GSM30811 IFC 03 68.3
GSM30812 IFC 04 64.9
GSM30813 IFC 05 67.6
GSM99800 isoflurane 01 male, 275-300g 46.2
GSM99801 isoflurane 02 male, 275-300g 11.4
GSM99802 isoflurane 03 male, 275-300g 69.4
GSM99803 isoflurane 04 male, 275-300g 74.4
GSM99804 isoflurane 05 male, 275-300g 44.9

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 239.4909
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 227.3659
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 182.7276
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 185.7442
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 161.9323
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 203.9231
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 101.8773
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 150.7225
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 211.4509

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 4.79375
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 5.05851
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 5.0221
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 5.2579
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 4.44278
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 5.29507
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 4.6464
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 5.03654
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 4.78506
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 5.26283
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 5.5624
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 5.59659
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 4.58096
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 5.39733
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 4.97559
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 4.31093

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 9.123559
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.729693
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.744001
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.385768
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.999427
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.805907
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.457611
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.835812
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.754024
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.999105
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.394296
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.732837
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.065517
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.080953
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.483155
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.65677
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.306299
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.968826
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.19035
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.997307
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.83039
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 9.462877
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.572015
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 9.711906
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.792396
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 10.761772
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 10.788878
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 11.35026
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 10.881363
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 10.467066
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.225577
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.107358
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.308514
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.19652
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 10.931378
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 11.072395
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 10.933137
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 10.611218
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 11.301822
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 11.3993
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.797666
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.670839
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.094104
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.973042
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.602895

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 21.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 21.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 17.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 21.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 19.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 15.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 11.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 21.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 15.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 25.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 18.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 32.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 24.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 21.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 11.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 17.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 17.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 30.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 29.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 12.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 24.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 20.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 20.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 25.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 13.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 16.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 16.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 16.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 20.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 16.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 19.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 21.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 19.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 17.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 20.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 13.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 13.104719
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 9.778394
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 20.114677
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 10.193306

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; -0.00823
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 -0.0338
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 0.00312
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.151
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 -0.0406
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 -0.0534
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 -0.00256
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 -0.0687
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 0.0176
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.0329
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.0548
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 -0.0162

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 14.5
GSM5121 Isoflurane single exposure control-2 9.7
GSM5122 Isoflurane single exposure control-3 11.05
GSM5124 Isoflurane single exposure 1 hr-1 21.95
GSM5126 Isoflurane single exposure 1 hr-2 9.65
GSM5127 Isoflurane single exposure 2 hr-1 8.95
GSM5130 Isoflurane single exposure 2 hr-2 12.0
GSM5131 Isoflurane single exposure 2 hr-3 22.299999999999997

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 9.189064499
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 9.467637524
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 9.853223717
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 10.32190803
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 10.17980694
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 9.788549439
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 8.592218097
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 10.33482438
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 9.693767969
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 9.668994817
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 9.459493156
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.899300683
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 10.18343107
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 9.451804213
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 9.79415724
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 9.739760165
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 8.088037529
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 9.304047629
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 8.99643454
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 9.188065548
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 9.03454258
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 9.882605027
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 9.75327597
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 9.550120259

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.660911
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.673196
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.698902
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.42525
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.369972
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.670325
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.452578
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.5729
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.540473
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.501048
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.476273
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.819019
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.376445
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.742116
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.560952
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.827773
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.444695
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.68339
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.817746
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.563967
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.448399
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.426854
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.642662
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.636036

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 444.8011
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 768.3603

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 468.0256269
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1345.716841
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1071.51356
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 907.9622085
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 1243.208041
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 624.9585834
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1224.407077
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1219.471049
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1077.195482
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1072.206998
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1128.995192
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 640.13877
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 2029.451681
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1303.589635

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 9.189064499
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 9.467637524
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 9.853223717
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 10.32190803
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 10.17980694
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 9.788549439
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 8.592218097
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 10.33482438
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 9.693767969
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 9.668994817
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 9.459493156
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.899300683
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 10.18343107
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 9.451804213
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 9.79415724
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 9.739760165
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 8.088037529
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 9.304047629
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 8.99643454
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 9.188065548
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 9.03454258
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 9.882605027
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 9.75327597
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 9.550120259
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 468.0256269
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1345.716841
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1071.51356
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 907.9622085
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 1243.208041
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 624.9585834
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 1224.407077
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1219.471049
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1077.195482
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1072.206998
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1128.995192
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 640.13877
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 2029.451681
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1303.589635

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 22.0
GSM5084 Control 2 20.45
GSM5085 Control 3 18.25
GSM5086 Control 4 22.400000000000002
GSM5087 Control 5 26.05
GSM5090 Control 6 21.05
GSM5105 Control 7 26.0
GSM5106 Control 8 21.599999999999998
GSM5107 Control 9 19.8
GSM5108 Halothane 10 exposure-1 15.3
GSM5109 Halothane 10 exposures-2 20.9
GSM5110 Halothane 10 exposures-3 18.3
GSM5111 Halothane 5 exposures-1 19.9
GSM5112 Halothane 5 exposures-2 24.0
GSM5113 Halothane 5 exposures-3 7.949999999999999
GSM5114 Isoflurane 10 exposures-1 16.7
GSM5115 Isoflurane 10 exposures-2 38.55
GSM5116 Isoflurane 10 exposures-3 12.2
GSM5117 Isoflurane 5 exposures-1 20.7
GSM5118 Isoflurane 5 exposures-2 23.7
GSM5119 Isoflurane 5 exposures-3 15.2
GSM11379 Control 10 17.6
GSM11380 Control 11 22.1
GSM11381 Control 12 27.8

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 27.9305
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 35.2926